X0306 4 2019-07-15 0 0001058057 MARVELL TECHNOLOGY GROUP LTD MRVL 0001381430 MURPHY MATTHEW J 5488 MARVELL LANE SANTA CLARA CA 95054 1 1 0 0 CEO and President Common Shares 2019-07-15 4 M 0 47636 0.00 A 407595 I By Trust Common Shares 2019-07-15 4 F 0 25081 26.01 D 382514 I By Trust Common Shares 2019-07-15 4 M 0 11598 0.00 A 394112 I By Trust Common Shares 2019-07-15 4 F 0 6107 26.01 D 388005 I By Trust Common Shares 2019-07-15 4 M 0 8556 0.00 A 396561 I By Trust Common Shares 2019-07-15 4 F 0 4505 26.01 D 392056 I By Trust Common Shares 2019-07-15 4 A 0 210156 0.00 A 602212 I By Trust Common Shares 2019-07-15 4 F 0 110648 26.01 D 491564 I By Trust Common Shares 2019-07-15 4 A 0 137652 0.00 A 629216 I By Trust Common Shares 2019-07-15 4 F 0 72474 26.01 D 556742 I By Trust Common Shares 2019-07-16 4 S 0 15000 25.805 D 541742 I By Trust Common Shares 2019-07-17 4 S 0 250000 26.0341 D 291742 I By Trust Common Shares 1755 D Restricted Stock Units 2019-07-15 4 M 0 47636 0.00 D Common Stock 47636 0 D Restricted Stock Units 2019-07-15 4 M 0 11598 0.00 D Common Stock 11598 127584 D Restricted Stock Units 2019-07-15 4 M 0 8556 0.00 D Common Stock 8556 59898 D Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). Each RSU represented a contingent right to receive one Marvell Technology Group Ltd. ("Marvell") common share upon vesting. This grant is fully vested. The remaining RSUs vest quarterly on each of 10/15/2019, 01/15/2020, 04/15/2020, 07/15/2020, 10/15/2020, 01/15/2021, 04/15/2021, 07/15/2021, 10/15/2021, 01/15/2022 and 04/15/2022. The remaining RSUs vest quarterly on each of 10/15/2019, 01/15/2020, 04/15/2020, 07/15/2020, 10/15/2020, 01/15/2021, and 04/15/2021. Mr. Murphy vested as to 105,078 shares at target and as to 105,078 shares above target pursuant to the terms of the PSU RSU grant made to Mr. Murphy on August 11, 2016. Mr. Murphy vested as to 105,078 shares at target and as to 32,574 shares above target pursuant to the terms of the TSR RSU grant made to Mr. Murphy on August 11, 2016. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.61 to $26.14, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The sales reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.69 to $26.27, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Matthew Murphy by Blair Walters attorney-in-fact 2019-07-17